Karnani Vikram — SEC insider filings
SEC reporting owner CIK 1699488. 10 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2021-01-06 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 41,120 shares, $3,190,815 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 30,031 shares @ $75.00 ($2,252,325) in Horizon Therapeutics Public Ltd Co, filed 2021-01-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Horizon Therapeutics Public Ltd Co (HZNP) | EVP & President, International | 5 | — | 4 legs · 41,120 sh · $3,190,815 | 14 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | President and CEO, Director | 4 | — | — | 7 |
| Dyne Therapeutics, Inc. (DYN) | Director | 1 | — | — | 1 |
Insider filings — Karnani Vikram
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Tax withholding (F): 11,737 @ $24.95 | EDGAR |
| 2026-02-12 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 79,264 @ $0 · Grant/award (A): 32,531 @ $0 · Tax withholding (F): 11,296 @ $46.75 | EDGAR |
| 2025-12-23 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 59,665 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Tax withholding (F): 8,983 @ $47.35 | EDGAR |
| 2024-11-14 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 105,972 @ $0 · Grant/award (A): 130,344 (derivative) @ $0 | EDGAR |
| 2021-02-23 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Sale (S): 7,713 @ $87.08 · Sale (S): 645 @ $88.45 | EDGAR |
| 2021-02-19 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Grant/award (A): 1,965 @ $0 · Tax withholding (F): 871 @ $87.17 · Grant/award (A): 3,931 (derivative) @ $0 · Grant/award (A): 14,512 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 4,904 @ $0 · Tax withholding (F): 2,173 @ $77.43 · Sale (S): 2,731 @ $76.81 · Option exercise (M): 4,904 (derivative) @ $0 | EDGAR |
| 2021-01-08 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Sale (S): 30,031 @ $75 | EDGAR |
| 2021-01-06 | 4 | Horizon Therapeutics Public Ltd Co (HZNP) | Option exercise (M): 47,337 · Grant/award (A): 65,088 @ $0 · Tax withholding (F): 49,906 @ $73.28 · Grant/award (A): 20,957 (derivative) @ $0 · Option exercise (M): 17,983 (derivative) @ $0 · Option exercise (M): 17,260 (derivative) @ $0 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1699488 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs